Surrozen, Inc. (NASDAQ:SRZN – Get Rating) was the target of a large decline in short interest during the month of January. As of January 15th, there was short interest totalling 227,300 shares, a decline of 18.7% from the December 31st total of 279,700 shares. Approximately 1.2% of the company's stock are sold short. Based on an average daily volume of 812,000 shares, the short-interest ratio is currently 0.3 days.

Surrozen Price Performance

NASDAQ:SRZN remained flat at $0.72 during midday trading on Friday. 409,438 shares of the company traded hands, compared to its average volume of 753,427. The stock has a fifty day moving average of $0.60 and a two-hundred day moving average of $1.85. Surrozen has a 12-month low of $0.34 and a 12-month high of $3.97.

Surrozen (NASDAQ:SRZN – Get Rating) last announced its quarterly earnings results on Monday, November 14th. The company reported ($0.38) EPS for the quarter, topping the consensus estimate of ($0.43) by $0.05. On average, sell-side analysts anticipate that Surrozen will post -1.46 EPS for the current year.

Institutional Inflows and Outflows

Wall Street Analysts Forecast Growth

SRZN has been the subject of several recent analyst reports. JPMorgan Chase & Co. cut shares of Surrozen from a "neutral" rating to an "underweight" rating in a research report on Tuesday, November 29th. Guggenheim cut shares of Surrozen from a "buy" rating to a "neutral" rating in a research report on Friday, November 18th. Finally, Bank of America cut shares of Surrozen from a "neutral" rating to an "underperform" rating in a research report on Wednesday, November 16th.

Surrozen Company Profile

(Get Rating)

Surrozen, Inc, a biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair and regeneration. It is developing tissue-specific antibodies with application across various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, and central nervous system.

Read More

• Get a free copy of the StockNews.com research report on Surrozen (SRZN)
• MarketBeat Week in Review – 1/23- 1/27
• Why Lucid Spiked Nearly 100% In One Day
• Ride These Railroad Stocks for Growth and Income
• ASML Sees Demand For Chips Rallying This Year, Boosts Sales View
• KLA Corporation: Strength In A Troubled Semi-Market

Receive News & Ratings for Surrozen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surrozen and related companies with MarketBeat.com's FREE daily email newsletter.